GENEVA, July 3 -- RECODE THERAPEUTICS, INC. (1140 O'Brien DriveMenlo Park, California 94025), THE BOARD OF THE REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (210 West 7th StreetAustin, Texas 78701), SIEGWART, Daniel J. (c/o UT Southwestern Medical Center5323 Harry Hines Blvd.Dallas, Texas 75390), CHATTERJEE, Sumanta (c/o The Board of the Regents of The University of Texas System210 West 7th StreetAustin, Texas 78701), SUN, Yehui (c/o The Board of the Regents of The University of Texas System210 West 7th StreetAustin, Texas 78701), MOHAPATRA, Sakya (c/o ReCode Therapeutics, Inc.1140 O'Brien DriveMenlo Park, California 94025) filed a patent application (PCT/US2024/061579) for "GENE EDITING METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS" on...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.